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I read with interest the article by Dr Huang et al [1]. Although
the serum CA-125 level is a well-known tumor-associated antigen,
it is neither a very sensitive nor a very speciﬁc tumor marker for
endometrioma or endometriosis, or even for ovarian cancer. This
viewpoint has been discussed thoroughly in the “Discussion” sec-
tion of the original article. However, I have some questions about
the data presented on the CA-125 level (Table 1 of the original
article). The preoperative serum CA-125 level was
278.48 ± 639.35 IU/mL. I do not know how to interpret this data.
Can the individual measurement of CA-125 be grouped together
like this? The CA-125 level is an individual data used to compare
with the patient herself. A CA-125 level <35 IU/mL, or 70 IU/mL,
is considered normal. However, some experts suggest that the
reference values may range from 20 IU/mL to 200 IU/mL. Serial
measurement of serum CA-125 levels might be useful as a tumor
marker. Therefore, it is very difﬁcult to understand the data
presented.
I examined the CA-125 levels presented in Table 2 of the original
article. First, the preoperative serum CA-125 level of patients who
underwent surgery within 72 hours of endometrial rupture was
232 ± 652.95 IU/mL. Again, how did the authors arrive at this
value? In addition, how were they able to compare this value
with that of patients who underwent surgery after 72 hours and
report p ¼ 0.442. If the data were presented as mean, then the
serum CA-125 level of patients who underwent surgery within
72 hours (i.e., 232 IU/mL) was approximately 232/95.55¼ 2.5 times
higher than that of patients who underwent the surgery after
72 hours. What does this mean?
Second, the postoperative serum CA-125 level for patients who
underwent surgery after 72 hours of endometrial rupture was
92.23 ± 155.86. The same question here as well: How did the au-
thors arrive at this value? In addition, how were they able to
compare this value with that of patients who underwent surgeryhttp://dx.doi.org/10.1016/j.tjog.2014.11.019
1028-4559/Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Publishedwithin 72 hours and report p ¼ 0.243. If the data were presented
as mean again, then the serum CA-125 level of patients who under-
went surgery after 72 hours was 92.23/40.67 ¼ 2.2 times higher
than that of patients who underwent the surgery within 72 hours.
What does this mean? Based on these data, the conclusion should
have been made only after the surgical intervention: the serum CA-
125 level dropped for patients who received surgery within
72 hours, but not for patients who received surgical intervention af-
ter 72 hours. The authors presented the concluding remarks based
on their opinion.
Third, because most patients (13/14) among those who received
surgery after 72 hours underwent laparoscopy, I am interested in
knowing exactly when blood was drawn from these 13 patients,
and from the other patient who underwent laparotomy. In Table
2 of the original article, the pre- and postoperative serum CA-125
levels for patients who underwent surgery after 72 hours are re-
ported as 95.55 IU/mL and 92.23 IU/mL, respectively.
In conclusion, an analysis of CA-125 levels alone cannot be used
as a factor to diagnose endometrioma ruptured or exclude an unex-
pected malignancy.
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